Drug pipeline
Explore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
78 kDa glucose-regulated protein (GRP78), also known as HSPA5 or BiP, is a member of the heat shock protein 70 (HSP70) family that primarily functions as a molecular chaperone in the endoplasmic reticulum (ER) [UniProt P11021]. While typically resident in the ER to assist in protein folding and the unfolded protein response (UPR), GRP78 translocates to the cell surface (csGRP78) under conditions of cellular stress, particularly in cancer cells. On the cell surface, it acts as a multifunctional receptor, activating pro-survival signaling pathways such as PI3K/Akt and MAPK, which promote tumor growth, metastasis, and chemoresistance. Because csGRP78 is preferentially expressed on malignant cells and not on most normal tissues, it has emerged as a promising therapeutic target for monoclonal antibodies, peptides, and drug conjugates. Therapeutic strategies include direct inhibition of its chaperone activity, induction of apoptosis, or utilizing it as a docking site for targeted delivery of cytotoxic agents.
Inhibition of chaperone activity, induction of apoptosis via the unfolded protein response, blockade of pro-survival signaling pathways (e.g., PI3K/Akt), and antibody-dependent cellular cytotoxicity (ADCC) targeting cell-surface localized protein.
6 more in the full profile.
Source types: Peer-reviewed publication. Sources are available to Gosset users. Log in to see them.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on 78 kDa glucose-regulated protein (GRP78).